Bonus BioGroup
Press Room

Press Releases 2016

Press Releases 2016 (6)

Bonus BioGroup Announces Revolutionary Medical Breakthrough

Successful Outcome in First Clinical Trial: Safe, Rapid and Efficient Reconstruction of Maxillofacial Bone by the Company's Injectable Live Human Bone Graft was Achieved in All Subjects

Bonus BioGroup Announces Successful First Transplantation of Second-Generation Injectable Live Human Bone Graft in Clinical Trial for Maxillofacial Bone Repair

Bonus BioGroup announces today successful transplantation for the first patient in the Company's second clinical trial for the repair of maxillofacial bone deficiencies. The transplantation was performed a fortnight following collection of the patient's fat sample, and several weeks following the enrolment of the first three subjects.

One Week Following Receipt of Required Approvals for Second Clinical Trial

Bonus BioGroup Enrols First Three Subjects in Clinical Trial with Second Generation Live Injectable Bone Graft for Repair of Maxillofacial Deficiencies

Bonus BioGroup Expands Prospective Product Line

Successful Proof-Of-Concept Preclinical Study on the Development of Large Vascularized Human Bone Graft

Bonus BioGroup Raises 4 Million NIS at 70 Agorot per Share
Fundraised a total of 18 million NIS at a price 18% higher than the average stock exchange and intends to register all of its shares for trade in the US, at the NASDAQ or NYSE.

Bonus BioGroup Receives Israeli Ministry of Health Approval for Clinical Trial Testing Second Generation Injectable Human Bone Graft for Maxillofacial Repair


Press Release, Announcements publication and more

Bonus BioGroup



Terms of UsePrivacy Policy | Login        

© 2021 Bonus BioGroup Ltd. All Rights Reserved. Designed By Netron Israel Ltd.